Bayer will pump about €5bn (about R83bn) of its research & development budget into alternatives to its weedkiller, glyphosate, over the next decade as it battles more than 13,000 lawsuits claiming the herbicide causes cancer.

BL Premium

This article is reserved for our subscribers.

A subscription helps you enjoy the best of our business content every day along with benefits such as exclusive Financial Times articles, Morningstar financial data, and digital access to the Sunday Times and Times Select.

Already subscribed? Simply sign in below.



Questions or problems? Email helpdesk@businesslive.co.za or call 0860 52 52 00.